22840-2609 : Paecilomyces Variotii 40000 [Pnu]/Ml Intradermal; Percutaneous; Subcutaneous Solution
NDC: | 22840-2609 |
Labeler: | Greer Laboratories, Inc. |
Product Type: | Non-standardized Allergenic |
Drug Name: | Paecilomyces Variotii |
Dosage Form: | Intradermal; Percutaneous; Subcutaneous Solution |
Application #: | BLA101833 |
Rev. Date: |
NDC Package Codes:
- 22840-2609-2: 10 ML IN 1 VIAL, MULTI‑DOSE (22840‑2609‑2)
- 22840-2609-4: 50 ML IN 1 VIAL, MULTI‑DOSE (22840‑2609‑4)
Active Ingredients:
- Paecilomyces Variotii
Dosage Strength:
- 40000 [PNU]/mL
Pharmaceutical Classes:
- Non-Standardized Fungal Allergenic Extract [EPC]
- Increased Histamine Release [PE]
- Cell-mediated Immunity [PE]
- Increased IgG Production [PE]
- Fungal Proteins [CS]
- Allergens [CS]
Related Products:
Based on records with the same trade name.- 22840-2605 Paecilomyces Variotii .1 g/ml Intradermal; Percutaneous; Subcutaneous Solution by Greer Laboratories, Inc.
- 22840-2606 Paecilomyces Variotii 20000 [Pnu]/Ml Intradermal; Percutaneous; Subcutaneous Solution by Greer Laboratories, Inc.
- 22840-2607 Paecilomyces Variotii 1000 [Pnu]/Ml Intradermal; Percutaneous; Subcutaneous Solution by Greer Laboratories, Inc.
- 22840-2608 Paecilomyces Variotii .001 g/ml Intradermal; Percutaneous; Subcutaneous Solution by Greer Laboratories, Inc.
- 22840-2673 Paecilomyces Variotii .05 g/ml Intradermal; Percutaneous; Subcutaneous Solution by Greer Laboratories, Inc.
- 22840-5629 Paecilomyces Variotii .05 g/ml Intradermal; Percutaneous; Subcutaneous Solution by Greer Laboratories, Inc.
NDC QR Code
Scan the QR code below to easily reference this data in the future:< Prev: 22840-2608Next: 22840-2610 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.